SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sparrow Pharmaceuticals Expands Cohorts in Phase 2b Diabetes Trial

Sparrow Pharmaceuticals announced expansion cohorts in its Phase 2b CAPTAIN-T2D trial to evaluate clofutriben across a range of cortisol levels in difficult-to-control type 2 diabetes.

Related stories